Nursing and Health Professions
Patient
100%
Lamivudine
83%
Follow up
50%
Dolutegravir
50%
Drug
33%
Clinical Practice
16%
Adverse Event
16%
DNA
16%
Linear Regression Analysis
16%
Man
16%
Time
16%
Cholesterol Blood Level
16%
Laboratory
16%
Parameters
16%
Metabolic Parameters
16%
High Density Lipoprotein Cholesterol
16%
Low Density Lipoprotein Cholesterol
16%
CD4 CD8 Ratio
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lamivudine
83%
Dolutegravir
50%
HIV
33%
Drug
33%
Mixed Model
33%
Adverse Event
16%
Low Density Lipoprotein Cholesterol
16%
DNA
16%
High Density Lipoprotein Cholesterol
16%
Observational Study
16%
Neuroscience
Lamivudine
83%
Dolutegravir
50%
HIV
33%
DNA
16%
CD4
16%
Low Density Lipoprotein Cholesterol
16%
High Density Lipoprotein Cholesterol
16%
Suppression
16%
Communication
16%
Immunology and Microbiology
Human Immunodeficiency Virus
33%
Age
16%
Cholesterol Blood Level
16%
CD4
16%
CD4 CD8 Ratio
16%
Time
16%
Cells
16%
Life
16%
Psychology
Treatment
83%
Linear Regression
16%
Communication
16%
Regression Analysis
16%